Adamas Announces New Employment Inducement Grants

Rhea-AI Summary

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) announced the granting of restricted stock units for 106,500 shares to eight new employees. These units will vest over three years and were issued under the 2016 Inducement Plan, approved by the board in March 2016, as per Nasdaq regulations. This move aims to attract talented individuals to bolster the company's workforce, which is focused on developing innovative therapies for neurological diseases.

Positive

• Granting of restricted stock units may enhance talent acquisition.
• The vesting schedule over three years aligns employee interests with shareholder value.

Negative

• None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted eight new employees restricted stock units to acquire 106,500 shares of the company’s common stock. The restricted stock units vest over three years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211008005299/en/

Media:

Sarah Mathieson

Vice President, Corporate Communications

510-450-3528

smathieson@adamaspharma.com

Investors:

Peter Vozzo

Westwicke Partners

443-213-0505

peter.vozzo@westwicke.com

Source: Adamas Pharmaceuticals, Inc.

FAQ

What stock options were granted to new employees at Adamas Pharmaceuticals?

Adamas Pharmaceuticals granted 106,500 restricted stock units to eight new employees.

How long is the vesting period for the restricted stock units at Adamas Pharmaceuticals?

The restricted stock units will vest over a period of three years.

Under which plan were the stock units granted at Adamas Pharmaceuticals?

The restricted stock units were granted under the 2016 Inducement Plan.

Why did Adamas Pharmaceuticals grant restricted stock units?

The stock units were granted to attract new employees to the company.

When was the 2016 Inducement Plan approved for Adamas Pharmaceuticals?

The 2016 Inducement Plan was approved in March 2016.